The report provides market dynamics and trends related to the global anti-rheumatics market. In addition, it presents estimations and forecast of the market. It includes revenue generated from the sales of products such as disease modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others, which are provided by key players. For the purpose of analysis, the global anti-rheumatics market is segmented on the basis of drug class, type, and region. The study estimates the revenue generated from anti-rheumatics. By drug class, the market is divided into disease modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others. Moreover, for better understanding of the use of anti-rheumatics market, it is further divided by type into prescription-based drugs and over-the-counter drugs. In addition, the report covers revenue generated from the sales of anti-rheumatics in regions such as North America, Europe, Asia-Pacific, and LAMEA.

INTRODUCTION 

EXECUTIVE SUMMARY 

MARKET OVERVIEW 

ANTI-RHEUMATICS MARKET, BY DRUG CLASS 

ANTI-RHEUMATICS MARKET, BY DRUG CLASS 

ANTI-RHEUMATICS MARKET, BY REGION 

COMPANY PROFILES